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The mechanism by which agonist binding triggers pore opening in ligand-gated ion channels is poorly understood. Here, we used
unnatural amino acid mutagenesis to introduce subtle changes to the side chains of tyrosine residues (Tyr141, Tyr143, Tyr153, and
Tyr234), which dominate the 5-HT3 receptor binding site. Heterologous expression in oocytes, combined with radioligand binding data
and a model of 5-HT (serotonin) computationally docked into the binding site, has allowed us to determine which of these residues are
responsible for binding and/or gating. We have shown that Tyr 143 forms a hydrogen bond that is essential for receptor gating but does
not affect binding,whereas a hydrogenbond formedbyTyr153 is involved in bothbinding and gating of the receptor. The aromatic group
of Tyr234 is essential for binding and gating, whereas its hydroxyl does not affect binding but plays a steric role in receptor gating. Tyr141
is not involved in agonist binding or receptor gating but is important for antagonist interactions. These data, combinedwith a newmodel
of the nonliganded 5-HT3 receptor, lead to amechanistic explanation of the interactions that initiate the conformational change leading
to channel opening. Thus, we suggest that agonist entry into the binding pocket may displace Tyr143 and Tyr153 and results in their
formingnewhydrogenbonds. These bondsmay formpart of thenetworkof bond rearrangements that trigger the conformational change
leading to channel opening. Similar rearrangements may initiate gating in all Cys-loop receptors.
Key words: ligand-gated ion channel; Cys-loop receptor; 5-HT3 receptor binding site; hydrogen bond; unnatural amino acids; activation
mechanism; serotonin
Introduction
The 5-HT3 receptor is amember of theCys-loop family of ligand-
gated ion channels, which includes nicotinic ACh (nACh),
GABAA, and glycine receptors (Reeves and Lummis, 2002). These
receptors are pentameric, with each subunit having a large extra-
cellular domain and four transmembrane domains (M1–M4).
No x-ray crystal structures have yet been published for any of
these proteins, so the molecular details of ligand binding and
channel opening have to be inferred from lower resolution im-
ages, homologous proteins, and experimental evidence
(Miyazawa et al., 2003). The determination of the structure of the
ACh binding protein (AChBP) (Brejc et al., 2001), which is ho-
mologous to the extracellular domain of the nACh receptor
(nAChR), has had a particularly significant impact on this field
andhas beenused to create homology-basedmodels of the nACh,
GABAA, and 5-HT3 receptors (Cromer et al., 2002; Le Novere et
al., 2002; Schapira et al., 2002; Reeves et al., 2003). Cryo-electron
microscope images have also contributed significantly to our un-
derstanding of the structure of these receptors and have led to a
model of channel opening: agonist binding to the extracellular
domain causes a rotation, which is then transduced via the
M2–M3 loop to the pore-lining domain, M2. A twist in this re-
gion both removes the hydrophobic residues lining the channel
and widens the pore, thus allowing ions to flow (Miyazawa et al.,
2003). Although this is a plausible model, more experimental
data are required both to substantiate it and to determine the
molecular details of these processes.
The homology model of the 5-HT3 receptor (Reeves et al.,
2003) reveals a ligand-binding pocket containing a large propor-
tion of aromatic residues. Two of these residues are tryptophans,
one of which (Trp183) forms a cation- interaction with agonist
(Beene et al., 2002). There is also a phenylalanine (Phe226), but
most of the aromatic character is provided by tyrosines (Tyr141,
Tyr143, Tyr153, and Tyr234). Previous data (Venkataraman et
al., 2002; Price and Lummis, 2004) have shown the importance of
these residues in the binding and/or function of the receptor, but
it has not been possible to define their exact roles. Here, we com-
bined conventional mutagenesis with non-sense suppression
methodology to incorporate both natural and unnatural amino
acids into positions 141, 143, 153, and 234. The latter has allowed
us to examine the effects on function and ligand binding of subtle
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changes to these tyrosine residues (see Fig. 1) and, thus, precisely
define their roles. Assimilating these data with the homology
model of the 5-HT3 receptor binding site, into which 5-HT has
been computationally docked, has allowed us not only to confirm
the orientation of 5-HT in the agonist binding pocket but also to
determine which bonds are essential for receptor binding and/or
gating. Combining this information with a new model of the
ligand binding site in the closed state has led us to propose a
mechanism by which agonist binding could trigger the series of
conformational changes leading to channel opening.
Materials andMethods
Mutagenesis and preparation of cRNA and oocytes.Mutant 5-HT3A recep-
tor subunits were developed using pcDNA3.1 (Invitrogen, Abingdon,
UK) containing the complete coding sequence for the 5-HT3A(b) subunit
(GenBank accession number Ay605711) fromN1E-115 cells as described
previously (Hargreaves et al., 1996). For non-sense suppression, the ty-
rosine codonswere replaced individually by the non-sense codonTAG as
described previously (Beene et al., 2002). Mutagenesis reactions were
performed using the Kunkel method (Kunkel, 1985) and confirmed by
DNA sequencing. Wild-type and mutant receptor subunit coding se-
quences were then subcloned into pGEMHE (Liman et al., 1992). This
was linearized withNheI (New England Biolabs, Beverly,MA) and cRNA
synthesized using the T7 mMESSAGE mMACHINE kit (Ambion, Aus-
tin, TX). This was then injected into oocytes from Xenopus laevis, which
were prepared and maintained as described previously (Beene et al.,
2002). Experiments were performed 18–36 hr after injection.
Synthesis of tRNAand dCAamino acids.Unnatural amino acids (Fig. 1)
were chemically synthesized as nitroveratryloxycarbonyl-protected cya-
nomethyl esters and coupled to the dinucleotide dCA, which was then
enzymatically ligated to 74-mer THG73 tRNACUA as detailed previously
(Nowak et al., 1998). Immediately before coinjection with mRNA,
tRNA-aa was deprotected by photolysis (Kearney et al., 1996). Typically,
5 ng of mRNA and 25 ng of tRNA-aa were injected into stage V–VI
oocytes in a total volume of 50 nl. For control experiments, mRNA was
injected, first, in the absence of tRNA and, second, with the THG73
74-mer tRNA.
Characterization of mutant receptors. 5-HT-induced currents were re-
corded from individual oocytes using two-voltage electrode clamp with
either a GeneClamp 500 amplifier or an OpusXpress system (Axon In-
struments, Union City, CA). All experiments were performed at 22–
25°C. Serotonin (creatinine sulfate complex; Sigma, St. Louis, MO) was
stored as 25 mM aliquots at 80°C, diluted in calcium-free ND96, and
delivered to cells via computer-controlled perfusion systems. Glass mi-
croelectrodes were backfilled with 3 M KCl and had a resistance of 1
M. The holding potential was60 mV unless otherwise specified. To
determine EC50 values, 5-HT concentration-response data were fitted to
the Hill equation, I  [Imax(A)
n]/[EC50
n  (A)n], where Imax is the
maximal peak current, [A] is the concentration of agonist, and n is the
Hill coefficient.
Results
Validation of the non-sense suppressionmethod,
reintroduction of tyrosine
As an initial test of the validity of the non-sense suppression
method, tyrosine was incorporated via acylated tRNA at each of
the four positions (141, 143, 153, and 234). For the non-sense
suppression methodology to give reliable results, the EC50 values
and Hill coefficients for activation by 5-HT must be indistin-
guishable from each other and from those of the wild-type
5-HT3A homopentamer expressed in Xenopus oocytes.
All mutant mRNAs, when coinjected into Xenopus oocytes
with tRNA-Tyr molecules, produced functional receptors that
responded to application of 5-HT with an inward current that
desensitized in response to maintained 5-HT. The results shown
in Tables 1–4 establish that the EC50 values and Hill coefficients
obtained from141-Tyr, 143-Tyr, 153-Tyr, and 234-Tyr andwild-
type receptors were indeed similar to each other. This indicates
that the wild-type phenotype was successfully “rescued” by the
delivery of tRNA-Tyr molecules. For each receptor, maximal
5-HT-induced currents (Imax) were typically 0.8–2 A at a hold-
ing potential of60mV (Fig. 2). This suggests that the pGEMHE
vector can yield levels of full-length, correctly folded protein at
least as high as the original pAMV-PA vector (Nowak et al.,
1998). The efficiency of non-sense suppression has been esti-
mated at 10% (Nowak et al., 1995), and comparison of Imax
values for the wild-type 5-HT3A receptor expressed in oocytes
using pGEMHE to rescuedTAGmutant receptors suggests a sim-
ilar efficiency here.
No currents in response to application of high concentrations
of 5-HT (1mM) were detected from oocytes injected withmRNA
alone or with mRNA and tRNA not ligated to dCA-aa (THG73
74-mer tRNA). It therefore appears that transcripts, which have
been truncated by the inclusion of a stop codon at the position of
the mutated tyrosine residue, cannot produce functional recep-
tors. This is to be expected, because these truncated receptors
would contain none of the transmembrane regions required for
ion channel activity. We can also conclude that any amino acid
Figure 1. Structures of the side chains of the unnatural amino acids used in this study.
Table 1. EC50 values (M) and Hill coefficients for 5-HT activation of 141-Tyr mutant
receptors (n 3–6) (A) and 3Hgranisetron binding affinities of Tyr mutants (B)
A
141- EC50  SE nH  SE
Ala 2.73 0.15 2.68 0.40
Ser 4.70 0.38 2.02 0.31
Cha 3.14 0.40 1.92 0.21
Phe 0.92 0.06 2.80 0.44
4-F-Phe 1.32 0.05 2.47 0.17
F5-Phe 1.38 0.08 1.89 0.17
Tyr (WT) 1.16 0.04 2.76 0.20
mTyr 1.69 0.06 3.24 0.29
4-MeO-Phe 3.36 0.14 2.17 0.16
B
141- Kd (nM) n
Ala 8.97 2.44* 4
Ser NB 8
Phe 0.98 0.15 4
Tyr (WT) 0.32 0.035 7
The asterisk indicates a significant difference (p	 0.05) to Tyr. Substitutions have been approximately ordered by
increasing size. NB, No binding; WT, wild type. The asterisk data in B are from Price and Lummis (2004).
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that is incorporated into these four sites of themutant receptor is
specifically introduced by the injected tRNA-aa and not by the
endogenous tRNA population of the oocyte. Finally, the lack of
response from oocytes injected with mRNA and unacylated
tRNA shows that there is no detectable reacylation of tRNA with
naturally occurring amino acids in vivo by endogenous
synthetases.
Incorporation of unnatural amino acids
A subset of the unnatural aromatic amino acids shown in Figure
1 was selected for testing at each of the mutant positions. These
compounds were previously incorporated into the nAChR
(Nowak et al., 1995, 1998) and are therefore compatible with the
oocyte expression system. In addition to the naturally occurring
amino acids tyrosine and phenylalanine, the amino acids tested in-
cluded 3-OH-phenylalanine (subsequently referred to as metaty-
rosine or mTyr), homotyrosine (hTyr), L-DOPA, 4-methyl-
phenylalanine (4-Me-Phe), 4-fluoro-phenylalanine (4-F-Phe),
F3-phenylalanine (F3-Phe), F5-phenylalanine (F5-Phe), 4-methoxy-
phenylalanine (4-MeO-Phe), and cyclohexylalanine (Cha).
Data from a typical concentration-response experiment (4-F-
Phe at position 234) are shown in Figure 2. Although there were
changes in the EC50 values and Hill coefficients for some mutant
receptors (see below), activation and desensitization kinetics
were similar to wild type for all receptors incorporating unnatu-
ral amino acids that responded to 5-HT.
The data however did show that receptors containing any res-
idue apart from the natural tyrosine residues at any of the posi-
tions tested display lower Imax values; a typical examplewith some
of the position 234 mutants is shown in Figure 2. Because this
effect was observed for both incorporation of phenylalanine and
the unnatural amino acids, it probably did not arise because the
oocyte cellular machinery processes unnatural amino acids inef-
ficiently andmay be caused by lower levels of expression of some
mutant 5-HT3 receptors.
Tyr141 is not critical for function but may play a role in
antagonist binding and receptor assembly
Incorporation of Phe, mTyr, 4-F-Phe, 4-MeOPhe, F5-Phe, and
Cha using non-sense suppression mutagenesis and substitution
with the natural amino acids Ala, Ser, and Phe using standard
mutagenesis techniques produced receptors that responded to
5-HT in a manner very similar to wild-type 5-HT3A receptors
(Fig. 3; Table 1). These data therefore show that neither the aro-
matic nor the hydroxyl groups are important for agonist binding
or receptor gating. However, this residue has been implicated in
antagonist binding because changes in affinity of 5-HT3 receptor
antagonists have been observed when this residue is exchanged
for a nonaromatic (Venkataraman et al., 2002; Price and Lum-
mis, 2004). Thus, Tyr141Ala receptors have decreased [3H]gran-
isetron, D-tubocurarine, and lerisetron binding affinity com-
pared with wild-type receptors, whereas Tyr141Ser receptors do
Table 2. EC50 values (M) and Hill coefficients for 5-HT activation of 143-Tyr mutant
receptors (A) and 3Hgranisetron binding affinities of Tyr mutants (B)
A
143- EC50  SE nH  SE
Ala 354 29.0* 2.62 0.53
Ser 472 47.9* 2.68 0.62
Phe 78.6 2.86* 2.73 0.21
4-F-Phe NR NR
Tyr (WT) 1.15 0.03 2.98 0.19
mTyr NR NR
4-MeO-Phe NR NR
hTyr 33.24 2.60* 1.80 0.22*
L-DOPA 7.16 0.90* 2.34 0.54
B
143- Kd (nM) n
Ala 1.2 0.24 8
Ser 1.13 0.23 7
Phe 0.53 0.10 3
Tyr (WT) 0.32 0.035 7
Asterisks indicate a significant difference (p	 0.05) to Tyr (n 3–6). Data in B are from Price and Lummis (2004).
Substitutions have been approximately ordered by increasing size. NR, No response to concentrations of 5-HT up to
1 mM; NB, no binding; WT, wild type.
Table 3. EC50 values (M) and Hill coefficients for 5-HT activation of 153-Tyr mutant
receptors (n 3–6) (A) and 3Hgranisetron binding affinities of Tyr mutants (B)
A
153- EC50  SE nH  SE
Ala 120  9.43* 2.43 0.38
Ser 84.1  5.60* 2.54 0.37
Phe 22.5  0.43* 2.60 0.11
4-F-Phe 19.7  1.22* 1.82 0.14*
F5-Phe (
500)
Tyr (WT) 1.15 0.04 2.78 0.20
mTyr (
500)
4-Me-Phe 18.2  0.48* 2.48 0.11
4-MeO-Phe 6.65 0.27* 1.98 0.12*
B
153- Kd (nM) n
Ala 3.62 1.75* 3
Ser NB 6
Phe 0.90 0.20 5
Tyr (WT) 0.32 0.035 7
Data in B are from Price and Lummis (2004). Substitutions have been approximately ordered by increasing size. The
asterisk indicates a significant difference (p	 0.05) to Tyr. NB, No binding; WT, wild type.
Table 4. EC50 values (M) and Hill coefficients for 5-HT activation of 234-Tyr mutant
receptors using non-sense suppression (A) and 3Hgranisetron binding affinities
of Tyr mutants (B)
A
234- EC50  SE nH  SE
Ala 120 9.43* 2.43 0.38
Ser 84.1 5.60* 2.54 0.37
Phe 10.22 0.80* 1.92 0.26
Cha NR NR
4-F-Phe 4.11 0.20* 2.36 0.19
F3-Phe NR NR
F5-Phe NR NR
Tyr (WT) 1.24 0.05 2.89 0.28
mTyr 7.42 0.32* 2.83 0.32
4-Br-Phe 1.78 0.08 2.79 0.32
4-Me-Phe 1.13 0.05 2.49 0.22
B
234- Kd (nM) n
Phe 1.3 0.36 4
Ala NB 5
Ser NB 5
Tyr (WT) 0.32 0.035 7
Asterisks indicate a significant difference (p	 0.05) to Tyr (n 3.6). Data in B are from Price and Lummis (2004).
Substitutions have been approximately ordered by increasing size. NR, No response to concentrations of 5-HT up to
1 mM; NB, no binding; WT, wild type.
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not bind [3H]granisetron at all. Themodel of the 5-HT3 receptor
binding site (Fig. 4) [based on model 4 of Reeves et al. (2003)]
supports these data, because Tyr141 could contact these larger
antagonists but is not close enough to be in direct contact with a
bound 5-HT molecule.
In previous studies (Venkataraman et al., 2002; Price and
Lummis, 2004), Tyr141Ala and Tyr141Ser receptors did not
function when expressed in human embryonic kidney 293 cells.
However, our data show they have similar characteristics to wild-
type receptors when expressed in oocytes. Oocytes are generally
more tolerant thanmammalian cells to expression of ion channel
proteins, which may require longer periods to fold correctly, the
difference perhaps arising from the fact that oocytes are incu-
bated at lower temperatures, which would favor complex multi-
subunit assemblies (Denning et al., 1992). These data therefore
suggest a role for this residue in correct receptor folding and/or
assembly, perhaps locally in the binding site region.
Tyr143 forms a hydrogen bond that is essential for efficient
receptor gating
Data fromTyr143mutant receptors suggest that an aromatic ring
with a hydroxyl group at the 4 position is essential for efficient
receptor function: DOPA, which has these groups, was the only
Tyr143 substitute that produced receptors with a 	10-fold in-
crease in EC50. Incorporation of even subtle changes such as 4-F-
Phe, 4-MeO-Phe, and mTyr resulted in receptors that did not
respond to 5-HT (Table 2). DOPA also has a hydroxyl at the 3
position, and the increase in EC50 observed with this compound
(approximately sixfold) suggests that bulk here is not desirable.
An increased chain length or removal of the hydroxyl, however, is
more deleterious: Phe and hTyr caused 30- to 40-fold increases in
EC50. Removal of the aromatic group and/or further displace-
ment of the hydroxyl group, as in replacement with Ala or Ser,
resulted in even more severe changes: 
100-fold EC50 increases
and changes in apparent activation and desensitization rates, 10–
90% rise times were twofold to fourfold slower than wild-type
receptors (Fig. 3E), and the receptors displayed little or no desen-
sitization. These data demonstrate the importance of both the
aromatic and the hydroxyl group of Tyr143, and in particular
suggest that the hydroxyl forms a hydrogen bond that is essential
for efficient receptor gating.
To confirm the presence of such a bond would require x-ray
crystal structural data, which unfortunately is not available.
However, mutagenesis data alone are usually considered suffi-
cient, providing there is some supporting structural data such as
a homology model (Grutter et al., 2003). Indeed, the unnatural
amino acid methodology that we used here is a muchmore pow-
erful probe for this type of bond than conventional mutagenesis,
because we can not only introduce subtle changes that minimally
perturb the global protein structure but also design the amino
acid to determine whether the residue acts as a hydrogen bond
donor or acceptor. Thus, using conventionalmutagenesis, we can
remove the hydroxyl at position 143 (in Phe) but not replace it
(Ser is unsatisfactory as a replacement, because hydrogen bonds
depend critically on the distance between donor and acceptor
atoms, and the hydroxyls in these two residues are in quite dis-
tinct locations). Unnatural amino acid substitution can sur-
mount this problem; DOPA has a similarly placed hydroxyl to
Tyr, whereas 4-Me-O Phe places an O atom in the same location,
and the hydroxyl of hTyr is only subtly displaced from that of Tyr.
Data from these substitutions support the proposal of a hydrogen
bond at Tyr143 and indeed further suggest that the hydroxyl here
acts as a hydrogen bond donor.
Themodel of 5-HT docked into the 5-HT3A receptor extracel-
lular domain (Fig. 4) shows that the hydroxyl of Tyr143 has the
potential to hydrogen bond with one of a number of residues on
the opposite side of the binding pocket. These are the hydroxyl or
the  ring of Tyr234 and the carbonyl oxygens of Trp183 or
Leu184, all of which are	3Å away. The fact that 4-Me-Phe could
substitute satisfactorily for Tyr234 suggests that there is no such
bond between the hydroxyls of Tyr143 and Tyr234, but as yet we
cannot exclude any of the other possibilities. Of course the accu-
racy of the inter-residue distances must be viewed with caution,
both because of the problems inherent with using a model based
on a homologous structure and because, in the docking proce-
dure, the protein side chains remain rigid, which would not be
the case in vivo. Nevertheless, the modeling data suggest that the
most probable hydrogen bonding partner of Tyr143 is the back-
bone carbonyl of Trp183, an interaction that has also been pre-
viously suggested by Maksay et al. (2003).
The presence of either an aromatic or a hydroxyl at position
Figure 2. A, Exemplar concentration–response data obtained from two-electrode voltage-
clamp recordings from a single Xenopus oocyte expressing the 234–4-F-Phe mutant. B, Aver-
age readings ofmaximal current (Imax ) obtained for receptorswith substitutions of Tyr234. The
wild-type Tyr residue produced generally larger currents than Phe or the unnatural side chains,
but all residues studied gave responses adequate for systematic studies. C, Concentration–
response curves showing the effects of unnatural and natural aromatic amino acid residue
incorporation at position 234. Error bars (	10%) removed for clarity.
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143, however, is not essential for antagonist interactions: alanine,
serine, and phenylalanine mutants of Tyr143 bound [3H]granis-
etron with an affinity similar to wild-type receptors (Table 2)
(Venkataraman et al., 2002; Price and Lummis, 2004). Compet-
itive antagonists such as granisetron bind in the binding pocket
but cannot trigger the conversion to the open state. These data,
combined with the modeling data, thus suggest that neither an
aromatic group nor a hydrogen bond is required for ligand bind-
ing, but both are essential for efficient receptor gating.
A hydrogen bond formed by Tyr153 is involved in both
binding and gating of the receptor
Large increases in EC50 values (Table 3), modifications in recep-
tor kinetics (Fig. 3), and changes in [3H]granisetron binding af-
finity (Table 3) in mutant receptors suggest that Tyr153 plays a
role in both binding and gating of the receptor. The data show
that both an aromatic ring and a hydroxyl group in the 4 position
are required for correct receptor function. Therefore, removal of
the aromatic ring (Ala, F5Phe, Ser) re-
sulted in 100-fold EC50 increases,
whereas deleting the tyrosine hydroxyl
group (Phe) or replacing it (4-F-Phe or
4-Me-Phe) led to 20-fold increases in
EC50, and relocating it (mTyr and Ser) re-
sulted in100-fold EC50 increases. How-
ever, 4-MeO-Phe increased EC50 only six-
fold, indicating that the importance of the
hydroxyl is via its O atom. These data
strongly indicate the presence of a hydro-
gen bond, and the hydroxyl of Tyr153 acts
as a hydrogen bond acceptor. This hy-
droxyl is located such that it could partic-
ipate in a hydrogen bond interaction ei-
ther with the 5-HT indole nitrogen, 2.9 Å
away, or with Arg92 (3.1 Å). Arg92, like
Tyr153, is located on the subunit “inner
loop,” which is proposed to move relative
to the “outer loop” after receptor activa-
tion (Unwin et al., 2002). Because the rel-
ativemovement of the two residues during
channel opening would therefore be negli-
gible, it is unlikely that removing a hydro-
gen bond here would result in the changes
that we observed. We therefore propose
that Tyr153 hydrogen bonds to 5-HT.
The aromatic and hydroxyl groups of
Tyr234 play distinct roles
Replacement of tyrosine at this position
with Phe, 4-F-Phe, mTyr, and 4-Me-Phe
produced receptors for which EC50 values
for 5-HTactivationwere either unchanged
or increased 	10-fold compared with
wild-type receptors. Thus, the hydroxyl
group of Tyr234 is not essential for correct
receptor function. Indeed, the equivalent
residue here in the guinea pig 5-HT3 re-
ceptor is Phe, which, as we would have ex-
pected, has a slightly lowered EC50 value
compared with other species (Lankiewicz
et al., 1998). An aromatic grouphere, how-
ever, is important. A single F substituent
(4-F-Phe) caused an increase in EC50,
whereas multiple F substituents or removal of the aromatic ring
(Cha, Ala, or Ser) resulted in nonfunctional receptors. F is small
and nonbulky and therefore does not change the bulk of the
aromatic ring; however, it significantly affects its electronic struc-
ture, making it “less aromatic” as the number of Fs increase.
The data also suggest that a cation- interaction at Tyr234 is
unlikely (the electrostatic potential of the aromatic rings in ty-
rosine, Phe, and 4-F-Phe is Phe  Tyr 
4-F-Phe, but the EC50
values were Tyr	4-F-Phe	 Phe). This is interesting because in
the model (Fig. 4), this residue has the potential to interact with
the primary amine of 5-HT. It may be that the strength of the
cation- interaction between this group of 5-HT and Trp183
(estimated to be 4 kcal/mol) (Beene et al., 2002) renders an inter-
action with Tyr234 superfluous.
The pattern of EC50 values for unnatural amino acid substitu-
tion is consistent with bulk at the 4 position of the aromatic ring
being required for correct receptor function. Those residues with
a substituent at the 4 position (4-Me-Phe, 4-Br-Phe, and 4-F-
Figure 3. A, Typical response waveforms to 5-HT at approximately Imax and EC50 concentrations for wild type (WT) and each
mutant receptor that responded to 5-HT. Bars indicate 5-HT application. B, Concentration–response curves showing the effect of
replacing Tyr141, Tyr143, and Tyr153with alanine, serine, and (for Tyr143 only) phenylalanine. No responseswere detected from
oocytes injected with Tyr234Ala or Tyr234Ser RNA.
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Phe) give lower EC50 values than those without (Phe, mTyr).
Such a finding was reported for the aligning residue (Tyr198) in
the nACh receptor (Kearney et al., 1996), where a larger number
of unnatural residues were tested. The size of this substituent also
appeared to be important, with larger substituents not being tol-
erated and smaller ones also being less favored, suggesting a steric
role.
A newmodel of the 5-HT binding pocket
We previously docked 5-HT into a model of the 5-HT3 receptor
and used this model to further examine the data we report here
(Fig. 4). The new data strongly support our previous suggestion
that the correct orientation of 5-HT in the binding pocket is with
the amino group located betweenTrp183 andTyr234 and are also
consistent with hydrogen bonds between Tyr143 and Trp183,
and Tyr153 and 5-HT (Fig. 5). We also created a new “closed
state” model based on the data of Unwin et al. (2002). These data
indicate differences in the binding pocket between the closed
state of the nACh receptor and AChBP (which is considered to be
closer to the open state). In the closed state model, Tyr143 and
153 are 3 Å closer to the center of the pocket, and clashes between
these residues and 5-HT indicate that binding of this agonist in
the orientation supported by the experimental data is not possi-
ble (Fig. 5). Antagonist binding, however, would not be affected.
Thus, if we assume that similar movements in the binding pocket
occur in the nACh and 5-HT3 receptors, and that our newmodel
provides a reasonable approximation of the closed state of the
receptor, then Tyrs 143 and 153 would need to be displaced to
allow 5-HT to dock into the binding site (Fig. 5B). We await
high-resolution structural data to test this hypothesis.
Discussion
The in vivo non-sense suppression method of unnatural amino
acid incorporation is a powerful tool for the investigation of re-
ceptor structure–function relationships. Using a selection of
modified tyrosine and phenylalanine residues, we show that ty-
rosines located in or close to the receptor binding pocket each
play a different role in receptor function and do not simply pro-
vide a featureless extended aromatic environment. Thus, a ty-
rosine at position 141 is not critical, but for efficient function the
residues at position 143 and 153 form hydrogen bonds, and the
residue at position 234 should be an aromatic with an appropri-
ately sized substituent at the 4 position. These data, combined
with previous data that have shown that Trp183makes a cation-
interaction with the amine group of 5-HT (Beene et al., 2002),
have allowed us to define the orientation of 5-HT in a homology
model of the binding site and, combined with a new closed state
model, lead us to propose that a series of bond rearrangements
occur in the binding site that are required for gating and thusmay
be the trigger for the conformational changes that result in chan-
nel opening.
Roles of 5-HT3 receptor binding site tyrosine residues
Tyr141 does not play a critical role in 5-HT3 receptor agonist
binding or gating, but it may be involved in antagonist binding
and receptor assembly. The recent structure of AChBP bound to
agonists (Celie et al., 2004) shows that the residue equivalent to
Tyr141 (Leu102) hydrogen bonds to nicotine via a water mole-
cule. In our model of the 5-HT3 receptor, Tyr141 does not con-
tact 5-HT (and indeed in AChBP, residue Leu102 does not con-
tact carbachol) but does not preclude it interacting with larger
antagonists and/or to another residue in the binding pocket, per-
haps during subunit folding, to assist its correct formation.
Tyr143 is a sensitive residue in that it can only be replaced by
a limited number of alternative amino acids to form functional
receptors. Data from these mutant receptors (no change in
[3H]granisetron binding affinity and a large change in EC50)
combined with the modeling data (no interaction with 5-HT)
strongly suggest that Tyr143 forms a hydrogen bond between two
regions of the receptor that is essential for receptor gating. Our
data further suggest that this bond may be between the hydroxyl
group and the backbone carbonyl group of Trp183, which has
been previously suggested by Maksay et al. (2003). Previous data
have also shown the importance of this residue in 5-HT3 receptor
function (Venkataraman et al., 2002), and the equivalent residue
in AChBP (Arg104) has been shown to make contact with carba-
chol (Celie et al., 2004).
The data also strongly suggest that Tyr153 forms a hydrogen
bond, and that this bond plays a role in both binding and gating.
The equivalent residue in AChBP (Met114) makes contact with
both carbachol and nicotine (Celie et al., 2004), and data from
Figure 4. Model showing two views of 5-HT docked into the 5-HT3A receptor binding site.
This is based onmodel 4 of Reeves et al. (2003), which differs frommodel 5 by a small rotation
of the primary amine; all othermodels had adifferent orientation of 5-HT andare not supported
by the data. Tyrosine residues contributed from loops E (141, 143, 153, purple) and C (234,
orange) are indicated. The primary amine group of 5-HT is sandwiched between Trp183, where
there is a cation- interaction, and Tyr234. Tyr153 abuts the indole N.
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other studies also suggest that it is involved in gating. Venkatara-
man et al. (2002) have observed that Tyr153Alamutant receptors
display unusual response and desensitization kinetics, andmuta-
tion of the aligning residue in the GABAA receptor 2 subunit
(Thr142) resulted in the antagonist flumazenil acting as a partial
agonist (Mihic et al., 1994). Interestingly, the equivalent residue
in the 5-HT3B receptor is histidine (Hanna et al., 2000). Thus,
heteromeric (A plus B) rodent receptors would have this residue
at the binding site. This provides support for our suggestion that
the hydroxyl at Tyr153 acts as a hydrogen bond acceptor, because
histidine is one of relatively few amino acids for which side chains
can perform this function. The small shift in EC50 observed in
heteromeric receptors, however, suggests this bond is less
optimal.
Thus, our data show that the hydrogen bonds formed by
Tyr143 and Tyr153 are critical for correct receptor function, sug-
gesting these bonds play an important role in the conformational
change leading to gating. This could be because they stabilize the
bound state of the receptor and/or provide the energy required
for protein rearrangement.
An aromatic residue at position 234 is essential for 5-HT3
receptor function. Indeed conservation of an aromatic residue at
the aligning position among all 5-HT3 receptor subunits, and in
fact all Cys-loop receptors, indicates the importance of this aro-
matic group, which appears to play a vital role as part of the
“aromatic box” proposed to be critical for agonist binding in all
members of this ligand-gated ion channel family (Mu et al.,
2003). However, a substituent at the 4 position appears to be
important solely for gating, because antag-
onist binding is unaffected by removal of
the Tyr234 hydroxyl, and the docking data
suggest that there is no interaction be-
tween this group and 5-HT (Reeves et al.,
2003). The effect is steric, because hy-
droxyl and bromine, which have similar
sizes, yield optimum gating efficiency,
whereas smaller ones such as fluorine and
hydrogen function less effectively.
Amodel for initiating gating
The differences observed between AChBP
x-ray crystal data and nACh receptor cryo-
electron microscopy data suggest that
AChBP better represents the open rather
than the closed state of the receptor (Un-
win et al., 2002). Thus, the docking of
5-HT into the homology model of the
5-HT3 receptor binding site, as shown in
Figure 4, is likely to be broadly accurate,
whereas removal of 5-HT from this struc-
ture would not be a good representation of
the closed state. Data from Unwin et al.
(2002) show that in this region, the resi-
dues equivalent to Tyr143 and Tyr153 are
closer to the residues equivalent to Trp183
and Tyr234 in the unbound (closed state)
nACh receptor compared with AChBP
(open-like state). These changes in dis-
tance are likely to be only a few angstroms,
because the binding site is close to the
point around which the inner and outer
loops of the subunit pivot. Therefore, we
created a 5-HT3 receptor binding site
closed state model based on these data, which is shown in Figure
5A. Here, both Tyr143 and Tyr153 are 3 Å closer to the center of
the binding pocket. We propose that 5-HT entering the pocket
forms a cation- bond with Trp183 and, in doing so, displaces
Tyr143. The hydroxyl of Trp234 ensures that Tyr143 moves to-
ward and subsequently hydrogen bonds with Trp183 and not
with another E loop residue, as might be the case if formation of
the alternative rotamer was not prevented by the group located
here. Tyr153 is also relocated as 5-HT enters the pocket; assisted
by the hydrogen bond, it forms with the tertiary amine on this
molecule. These two residues are located on separate  sheets
linked by a turn and, therefore, their combined movement could
provide considerable torsional force. Combinedwith energy pro-
vided by the formation of hydrogen and other bonds, this could
initiate the twist that triggers the conformational change.
Some support for this hypothesis comes from docking studies
with the 5-HT3 receptor antagonist granisetron, which is not
expected to cause a conformational changewhen bound. A recent
report by Maksay et al. (2003) suggests that granisetron docked
into a homology model of the 5-HT3 receptor binding site does
not approach Tyr143 but does come relatively close to Tyr153
and interacts strongly with the aromatic group of Tyr234. Dock-
ing studies that we performed (K. L. Price and S. C. R. Lummis,
unpublished observations) similarly reveal potential interactions
of granisetron with Tyr234 and Tyr153 but not with Tyr143. One
orientation of granisetron that we observed, which is similar to
that reported by Maksay et al., (2003), is shown in Figure 5C.
Granisetron in this orientation would also fit comfortably into
Figure 5. A, Model of the 5-HT3 receptor binding site in the closed state; Tyr143 and Tyr153 are 3 Å closer to the center of the
pocket (created using SwissPdb viewer). B, Model of the 5-HT3 receptor binding site in the open state with 5-HT (purple) docked
(as in Fig. 4), showing potential new hydrogen bonds formed by Tyr143 and Tyr153. Other hydrogen bonds may also formwhen
the agonist binds (e.g., with Glu236), as discussed previously (Maksay et al., 2003; Reeves et al., 2003). C, Model of the 5-HT3
receptor binding site in the open state with granisetron (orange) docked using AUTODOCK based on the orientation favored by
Maksay et al. (2003). Granisetron, however, is most likely to bind to the closed state and, thus, theremay be some inaccuracies in
thismodel. Nevertheless, granisetron in this orientationwould fit into the closed statemodel (A), where it would bewithin 3 Å of
Tyr153but further fromTyr143.D, RotatedmodelAwith5-HT (purple) docked in the sameposition as inB. Steric interferencewith
Tyr143 and Tyr153 (green) would not allow 5-HT to be docked in this position.
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the closed statemodel, and indeed itmay hydrogen bondwith the
hydroxyl of Tyr153 (	3 Å distant) in this model.
Additional support comes from reports of movement in the
nACh receptor binding site (Miyazawa et al. 2003; Unwin et al.,
2002; Chakrapani et al., 2004) and in the GABAA receptor (Wag-
ner and Czajkowski, 2001), which is likely to be similar in all
Cys-loop receptors. However this has not yet been confirmed as
no ligand–free atomic resolution structure of AChBP has yet
been resolved. Thus we await with interest a high resolution
structure of an unbound ligand-gated ion channel binding region
to test the mechanistic aspects of our hypothesis.
In summary, the data obtained from introducing subtle
changes to tyrosine residues in the 5-HT3 receptor binding site,
combined with those obtained from models of the binding
pocket, have shown distinct roles of each of these residues in the
binding site. Combining these data with those from a model of
the binding pocket has allowed us to generate a hypothesis of the
mechanism that triggers the conformational change leading to
channel opening. The data therefore show the power of unnatu-
ral amino acidmutagenesis in providing high-precision informa-
tion that is highly complementary to modeling efforts. In addi-
tion, given the structural and functional similarity of ligand-
gated ion channels, we believe the proposed mechanism of
conformation change (agonist-stimulated movement of the
binding loops combined with the formation of novel bonds) will
be broadly similar in all members of the family.
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